Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 1
2018 2
2020 1
2021 3
2022 1
2023 2
2024 2
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
ARID1A in cancer: Friend or foe?
Fontana B, Gallerani G, Salamon I, Pace I, Roncarati R, Ferracin M. Fontana B, et al. Among authors: salamon i. Front Oncol. 2023 Feb 20;13:1136248. doi: 10.3389/fonc.2023.1136248. eCollection 2023. Front Oncol. 2023. PMID: 36890819 Free PMC article. Review.
Correlations Between Cardiac Magnetic Resonance and Myocardial Histologic Findings in Fabry Disease.
Ditaranto R, Leone O, Lovato L, Niro F, Cenacchi G, Papa V, Baldovini C, Ferracin M, Salamon I, Kurdi H, Parisi V, Capelli I, Pession A, Liguori R, Potena L, Seri M, Martin Suarez S, Galiè N, Moon JC, Biagini E. Ditaranto R, et al. Among authors: salamon i. JACC Cardiovasc Imaging. 2023 Dec;16(12):1629-1632. doi: 10.1016/j.jcmg.2023.06.011. Epub 2023 Aug 2. JACC Cardiovasc Imaging. 2023. PMID: 37542504 Free article. No abstract available.
Synergic activity of FGFR2 and MEK inhibitors in the treatment of FGFR2-amplified cancers of unknown primary.
Cavazzoni A, Salamon I, Fumarola C, Gallerani G, Laprovitera N, Gelsomino F, Riefolo M, Rihawi K, Porcellini E, Rossi T, Mazzeschi M, Naddeo M, Serravalle S, Broseghini E, Agostinis F, Deas O, Roncarati R, Durante G, Pace I, Lauriola M, Garajova I, Calin GA, Bonafè M, D'Errico A, Petronini PG, Cairo S, Ardizzoni A, Sales G, Ferracin M. Cavazzoni A, et al. Among authors: salamon i. Mol Ther. 2024 Oct 2;32(10):3650-3668. doi: 10.1016/j.ymthe.2024.07.011. Epub 2024 Jul 20. Mol Ther. 2024. PMID: 39033323 Free PMC article.
The Non-Coding RNA Journal Club: Highlights on Recent Papers-9.
Renwick N, El-Osta A, Salamon I, Broseghini E, Ferracin M, Poliseno L, Jankauskas SS, Santulli G, Xiao H, Shiu PKT, Roy S, Goel A. Renwick N, et al. Among authors: salamon i. Noncoding RNA. 2021 Sep 16;7(3):58. doi: 10.3390/ncrna7030058. Noncoding RNA. 2021. PMID: 34564320 Free PMC article.
Circulating microRNA biomarkers in melanoma and non-melanoma skin cancer.
Durante G, Broseghini E, Comito F, Naddeo M, Milani M, Salamon I, Campione E, Dika E, Ferracin M. Durante G, et al. Among authors: salamon i. Expert Rev Mol Diagn. 2022 Mar;22(3):305-318. doi: 10.1080/14737159.2022.2049243. Epub 2022 Mar 11. Expert Rev Mol Diagn. 2022. PMID: 35235479 Review.
Epigenetic age acceleration in hematopoietic stem cell transplantation.
Ursi M, Kwiatkowska KM, Pirazzini C, Storci G, Messelodi D, Bertuccio SN, De Matteis S, Iannotta F, Tomassini E, Roberto M, Naddeo M, Laprovitera N, Salamon I, Sinigaglia B, Dan E, De Felice F, Barbato F, Maffini E, Falcioni S, Arpinati M, Ferracin M, Bonafè M, Garagnani P, Bonifazi F. Ursi M, et al. Among authors: salamon i. Haematologica. 2025 Feb 1;110(2):481-484. doi: 10.3324/haematol.2024.285291. Haematologica. 2025. PMID: 39363850 Free PMC article. No abstract available.
Electrocardiogram evolution in Anderson-Fabry disease patients during follow-up in relation to specific treatment and cardiac disease progression.
Parisi V, Ditaranto R, Taglieri N, Di Nicola F, Baldassarre R, Schiavo MA, Nardi E, Lillo R, Meucci MC, Cianci A, Re F, Marchi G, Monda E, Capelli I, Donadio V, Cappelli F, Salamon I, Blanes JG, Girelli D, Pasquale F, Biffi M, Mignani R, Graziani F, Galiè N, Limongelli G, Olivotto I, Biagini E. Parisi V, et al. Among authors: salamon i. Int J Cardiol. 2025 Jul 15;431:133219. doi: 10.1016/j.ijcard.2025.133219. Epub 2025 Mar 29. Int J Cardiol. 2025. PMID: 40164319
Absolute quantification of cell-free microRNAs in cancer patients.
Ferracin M, Lupini L, Salamon I, Saccenti E, Zanzi MV, Rocchi A, Da Ros L, Zagatti B, Musa G, Bassi C, Mangolini A, Cavallesco G, Frassoldati A, Volpato S, Carcoforo P, Hollingsworth AB, Negrini M. Ferracin M, et al. Among authors: salamon i. Oncotarget. 2015 Jun 10;6(16):14545-55. doi: 10.18632/oncotarget.3859. Oncotarget. 2015. PMID: 26036630 Free PMC article.
Circulating miR-184 is a potential predictive biomarker of cardiac damage in Anderson-Fabry disease.
Salamon I, Biagini E, Kunderfranco P, Roncarati R, Ferracin M, Taglieri N, Nardi E, Laprovitera N, Tomasi L, Santostefano M, Ditaranto R, Vitale G, Cavarretta E, Pisani A, Riccio E, Aiello V, Capelli I, La Manna G, Galiè N, Spinelli L, Condorelli G. Salamon I, et al. Cell Death Dis. 2021 Dec 11;12(12):1150. doi: 10.1038/s41419-021-04438-5. Cell Death Dis. 2021. PMID: 34897278 Free PMC article.
16 results